KLF7
Basic information
Region (hg38): 2:207074137-207173856
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KLF7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 22 | 24 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 1 | 23 | 4 | 3 |
Variants in KLF7
This is a list of pathogenic ClinVar variants found in the KLF7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-207081229-A-G | Inborn genetic diseases | Uncertain significance (Mar 05, 2024) | ||
2-207081268-G-A | Uncertain significance (May 25, 2022) | |||
2-207088517-G-A | Benign (Mar 05, 2018) | |||
2-207088525-C-T | intellectual deficiency • KLF7-related disorder • Neurodevelopmental disorder • Inborn genetic diseases | Pathogenic/Likely pathogenic (Jul 05, 2023) | ||
2-207088530-C-T | Uncertain significance (Feb 07, 2024) | |||
2-207123806-G-T | Uncertain significance (Feb 09, 2024) | |||
2-207123885-C-A | Inborn genetic diseases | Uncertain significance (Mar 28, 2023) | ||
2-207123887-C-A | Uncertain significance (Oct 12, 2022) | |||
2-207123932-C-G | Inborn genetic diseases | Uncertain significance (Jan 02, 2024) | ||
2-207123941-G-A | Inborn genetic diseases | Uncertain significance (Apr 09, 2024) | ||
2-207124020-T-G | Uncertain significance (Sep 01, 2019) | |||
2-207124052-G-A | Inborn genetic diseases | Uncertain significance (Nov 13, 2023) | ||
2-207124056-T-C | Inborn genetic diseases | Uncertain significance (Jan 26, 2022) | ||
2-207124070-C-T | Inborn genetic diseases | Uncertain significance (May 27, 2022) | ||
2-207124071-G-C | Uncertain significance (Feb 14, 2024) | |||
2-207124082-G-A | Uncertain significance (Apr 08, 2022) | |||
2-207124083-G-T | Inborn genetic diseases | Uncertain significance (Mar 12, 2024) | ||
2-207124088-G-A | KLF7-related neurodevelopmental disorder | Uncertain significance (Jan 29, 2024) | ||
2-207124097-G-A | Inborn genetic diseases • KLF7-related neurodevelopmental disorder • Mild expressive language delay;Delayed gross motor development • Anxiety;Intellectual disability | Conflicting classifications of pathogenicity (Apr 04, 2024) | ||
2-207124109-A-C | KLF7-related disorder | Uncertain significance (Oct 28, 2022) | ||
2-207124114-G-A | KLF7-related disorder | Likely benign (Sep 05, 2019) | ||
2-207124135-G-A | KLF7-related disorder | Likely benign (Jan 13, 2020) | ||
2-207124179-G-A | Inborn genetic diseases | Uncertain significance (Jan 18, 2022) | ||
2-207124205-C-T | Inborn genetic diseases | Uncertain significance (Jul 20, 2021) | ||
2-207124220-T-G | Uncertain significance (Apr 15, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KLF7 | protein_coding | protein_coding | ENST00000309446 | 4 | 93131 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.982 | 0.0182 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.30 | 101 | 190 | 0.530 | 0.0000120 | 1960 |
Missense in Polyphen | 12 | 66.12 | 0.18149 | 688 | ||
Synonymous | -1.01 | 95 | 83.2 | 1.14 | 0.00000597 | 609 |
Loss of Function | 3.24 | 0 | 12.2 | 0.00 | 6.15e-7 | 146 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional activator. Binds in vitro to the CACCC motif of the beta-globin promoter and to the SP1 recognition sequence.;
- Pathway
- Adipogenesis
(Consensus)
Recessive Scores
- pRec
- 0.121
Intolerance Scores
- loftool
- 0.210
- rvis_EVS
- -0.43
- rvis_percentile_EVS
- 25.15
Haploinsufficiency Scores
- pHI
- 0.731
- hipred
- Y
- hipred_score
- 0.600
- ghis
- 0.600
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.904
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Klf7
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;axon guidance;regulation of epidermal cell differentiation;positive regulation of transcription by RNA polymerase II;dendrite morphogenesis;regulation of insulin secretion;negative regulation of adipose tissue development
- Cellular component
- nucleus
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;transcription coactivator activity;zinc ion binding